Back to search
FDAFDA · Food and drugs·Recall number D-420-2013

Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85

Published May 29, 2013 · Recall initiated: April 19, 2013

Summary

FDA records drug Class III recall D-420-2013, published May 29, 2013 and initiated April 19, 2013. Recalling firm: Novartis Consumer Health; Status: Terminated; Reported quantity: 3,828 Tubes; Lot: Lot #: 10118124, Exp: Sept 2013. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Novartis Consumer Health
Distributor
Nationwide
Lot
Lot #: 10118124, Exp: Sept 2013
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Lamisil AT (terbinafine hydrochloride cream 1% antifungal), 24 g (.85 oz) tube, Novartis Consumer Health, Parsippany, NJ 07054, NDC 0067-6171-85 recalled?

Yes. FDA published recall D-420-2013 on May 29, 2013. Reported hazard: Labeling: Incorrect or Missing Lot and/or Expiration date; The Lot and/or Expiration date on the tube may not be legible in this lot.

What should I do if I have this product?

Voluntary: Firm initiated · Letter